Intuitive Surgical VP Fredrik Widman sells $407,765 in common stock

Intuitive Surgical's VP Corporate Controller, Fredrik Widman, recently sold 1,089 shares of the company's common stock for $407,765 on September 15, 2026. The sale occurred under a Rule 10b5-1 trading plan and was executed at a price of $374.44 per share. Since Widman's transaction, the stock price has appreciated to $443.59, marking an 18% increase from the sale price.

With a market capitalization of $153.77 billion and a P/E ratio of 53.9, analysts at InvestingPro believe the stock is currently undervalued compared to its Fair Value. Additionally, Widman purchased 1,089 shares through the exercise of non-qualified stock options, buying them at prices ranging from $79.6378 to $109.4856 per share, for a total cost of $102,932.

These acquisitions come amid bullish sentiment, with 22 analysts revising their earnings estimates upward for the upcoming period. Widman currently directly owns 1,026 shares of Intuitive Surgical, along with 2,178 non-qualified stock options. Despite recent stock price fluctuations, Intuitive Surgical reported strong financial performance in its latest quarter, with revenue reaching $3.05 billion, surpassing both analyst estimates and company expectations.

However, the company's GAAP earnings per share fell short of projections at $1.49, affected by a $450 million litigation settlement. Strong segment performances in Systems, Services, and Instruments & Accessories contributed to surpassing revenue expectations by $140 million and EPS by $0.35. However, some analysts, including RBC Capital and Mizuho, have lowered their price targets for the stock, citing concerns about decelerated U.S. volume growth and slowing procedure growth.

Notably, Truist Securities has maintained a Buy rating with a $510 price target, citing significant capital demand and a 40% increase in net da Vinci placements, while Stifel has also retained a Buy rating and $550 price target. Overall, Intuitive Surgical's recent activities and financial performance have received mixed assessments from investors and analysts, reflecting the company's complex market positioning.